Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease

Atherosclerosis

Volumn 228, Issue 2, 2013, Pages 451-459

  Neumann, Johannes Tobias ^a   Tzikas, Stergios ^b   Funke Kaiser, Anne ^a   Wilde, Sandra ^a   Appelbaum, Sebastian ^a   Keller, Till ^a   Ojeda Echevarria, Francisco ^a   Zeller, Tanja ^a   Zwiener, Isabella ^b   Sinning, Christoph R ^a   Jagodzinski, Annika ^a   Schnabel, Renate B ^a   Lackner, Karl J ^b   Münzel, Thomas ^b   Blankenberg, Stefan ^a   Wild, Philipp S ^b   Sydow, Karsten ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Adrenomedullin; Biomarker; Cardiovascular disease; Cardiovascular risk factors; Reference values

Indexed keywords

MIDREGIONAL PROADRENOMEDULLIN; PROADRENOMEDULLIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FLUOROIMMUNOASSAY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RISK ASSESSMENT;

ADRENOMEDULLIN; ADULT; AGE FACTORS; AGED; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; FLUOROIMMUNOASSAY; GERMANY; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; UP-REGULATION;

EID: 84878113055     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.03.006     Document Type: Article

References (31)

1. Thygesen K., Mair J., Mueller C., et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J 2011 Feb 2.
2. Kitamura K., Kangawa K., Kawamoto M., et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophysical Res Commun 1993 Apr 30, 192(2):553-560. [Research Support, Non-U.S. Gov't].
3. Kitamura K., Kangawa K., Kojima M., Ichiki Y., Matsuo H., Eto T. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor. FEBS Lett 1994 Feb 7, 338(3):306-310. [Research Support, Non-U.S. Gov't].
4. Morgenthaler N.G., Struck J., Alonso C., Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 2005 Oct, 51(10):1823-1829. [Comparative Study].
5. Struck J., Tao C., Morgenthaler N.G., Bergmann A. Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 2004 Aug, 25(8):1369-1372. [Comparative Study].
6. Ishiyama Y., Kitamura K., Ichiki Y., et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 1993 Sep 14, 241(2-3):271-273.
7. Jougasaki M., Wei C.M., Aarhus L.L., Heublein D.M., Sandberg S.M., Burnett J.C. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol 1995 Apr, 268(4 Pt 2):F657-F663.
8. Kitamura K., Kangawa K., Eto T. Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions. Microsc Res Tech 2002 Apr 1, 57(1):3-13.
9. Bhandari S.S., Davies J.E., Struck J., Ng L.L. The midregional portion of proadrenomedullin is an independent predictor of left ventricular mass index in hypertension. Metabolism 2010 Jan, 59(1):7-13.
10. Al-Omari M.A., Khaleghi M., Mosley T.H., et al. Mid-regional pro-adrenomedullin is associated with pulse pressure, left ventricular mass, and albuminuria in African Americans with hypertension. Am J Hypertens 2009 Aug, 22(8):860-866.
11. Khan S.Q., O'Brien R.J., Struck J., et al. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. JAm Coll Cardiol 2007 Apr 10, 49(14):1525-1532. [Comparative Study].
12. Klip I.T., Voors A.A., Anker S.D., et al. Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. Heart 2011 Jun, 97(11):892-898.
13. Wild P.S., Schnabel R.B., Lubos E., et al. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study. Clin Chem 2011 Jan, 58(1):226-236.
14. Tzikas S., Keller T., Ojeda F.M., et al. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain. Heart 2012 Dec 4.
15. Brouwers F.P., de Boer R.A., van der Harst P., et al. Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population. Heart 2012 Jul 21.
16. Christ-Crain M., Morgenthaler N.G., Struck J., Harbarth S., Bergmann A., Muller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005, 9(6):R816-R824. [Comparative Study Evaluation Studies].
17. Maisel A., Mueller C., Nowak R.M., et al. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. JAm Coll Cardiol 2011 Aug 30, 58(10):1057-1067.
18. Potocki M., Breidthardt T., Reichlin T., et al. Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study. Crit Care 2009, 13(4):R122.
19. Masson S., Latini R., Carbonieri E., et al. The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial. Eur J Heart Fail 2010 Apr, 12(4):338-347.
20. von Haehling S., Filippatos G.S., Papassotiriou J., et al. Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail 2010 May, 12(5):484-491.
21. Tzikas S., Keller T., Wild P.S., et al. Midregional pro-atrial natriuretic peptide in the general population. Clin Chem Lab Med 2012 Nov 23, 1-9.
22. Schnabel R.B., Schulz A., Wild P.S., et al. Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging 2011 Jul, 4(4):371-380.
23. Wild P.S., Sinning C.R., Roth A., et al. Distribution and categorization of left ventricular measurements in the general population: results from the population-based Gutenberg Heart Study. Circ Cardiovasc Imaging 2010 Sep, 3(5):604-613.
24. Wild P.S., Zeller T., Beutel M., et al. The gutenberg health study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012 Jun, 55(6-7):824-830.
25. Sinning C., Wild P.S., Echevarria F.M., et al. Sex differences in early carotid atherosclerosis (from the community-based Gutenberg-Heart Study). Am J Cardiol 2011 Jun 15, 107(12):1841-1847.
26. Smith J.G., Newton-Cheh C., Hedblad B., et al. Distribution and correlates of midregional proadrenomedullin in the general population. Clin Chem 2009 Aug, 55(8):1593-1595.
27. Bhandari S.S., Davies J.E., Struck J., Ng L.L. Influence of confounding factors on plasma mid-regional pro-adrenomedullin and mid-regional pro-A-type natriuretic peptide concentrations in healthy individuals. Biomarkers 2011 May, 16(3):281-287.
28. Elmas E., Lang S., Dempfle C.E., et al. Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction. Int J Cardiol 2008 Aug 1, 128(1):107-111.
29. Mori T., Kai H., Kajimoto H., et al. Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: a possible mechanism of diastolic dysfunction in postmenopausal women. Hypertens Res 2011 Apr, 34(4):496-502.
30. Duzenli M.A., Ozdemir K., Sokmen A., et al. The effects of hormone replacement therapy on myocardial performance in early postmenopausal women. Climacteric 2010 Apr, 13(2):157-170.
31. Bhuiyan M.S., Fukunaga K. Characterization of an animal model of postmenopausal cardiac hypertrophy and novel mechanisms responsible for cardiac decompensation using ovariectomized pressure-overloaded rats. Menopause 2010 Jan-Feb, 17(1):213-221.